Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.
Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases.
A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.
In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations.
Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.
Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.